Skip to main content
. 2023 Apr 25;17(1):sfad099. doi: 10.1093/ckj/sfad099

Table 2:

Comparison of characteristics between exome-solved and -unsolved cases.

Variablea Unsolved (n = 155) Solved (n = 75) P-value
Age at ES (years) 46 [36–62] 50 [40–63] .25
Age at kidney disease onset or discovery 37 [24–50] 32 [20–49] .26
Male 98 (63.2) 35 (46.7) .02
Geographic origin .2
 Europe 116 (74.8) 57 (76)
 North Africa 17 (11) 14 (18.6)
 Sub-Saharan Africa 10 (6.5) 2 (2.7)
 French Antilles 5 (3.2) 2 (2.7)
 Asia 2 (1.3) 0
 Others 5 (3.2) 0
Consanguinity 13 (8.5) 12 (16) .1
Kidney disease onset before 35 years old 81 (52.3) 45 (60) .3
 With familial history 26 (16.8) 24 (32) .01
Familial history of kidney disease 63 (40.6) 52 (69.3) .0001
 First degree only 33 (21.3) 25 (33.3) .05
 Second degree only 13 (8.4) 6 (8) .9
 Both first and second degree 16 (10.3) 21 (28) .001
Prior negative genetic exploration with gene panel 22 (14.2) 12 (16) .7
ES first to avoid kidney biopsy 11 (7.1) 11 (14.7) .09
Prior inconclusive kidney biopsy 45 (29.2) 24 (32) .7
Impossible kidney biopsy 48 (31) 23 (30.7) 1
Undetermined clinical nephropathy subgroup
 Unclassified 57 (36.8) 31 (41.4)
 Glomerular 39 (25.2) 25 (33.3)
 Tubulointerstitial 23 (14.8) 7 (9.3) .3
 Cyst 23 (14.8) 9 (12)
 Vascular 13 (8.4) 3 (4)
Stage of kidney disease at ES
 I 22 (14.2) 10 (13.3)
 II 10 (6.5) 3 (4)
 III 28 (18.1) 11 (14.7)
 IV 20 (12.9) 12 (16) .3
 V 16 (10.3) 6 (8)
 V (D) 39 (25.2) 15 (20)
 V (T) 20 (12.9) 18 (24)